Psoriatic Arthritis: News

• Lags in Psoriatic Arthritis vs Rheumatoid Arthritis Care Patients with psoriatic arthritis experience longer delays in diagnosis, receive less intensive therapy, and show less improvement in disease activity than matched patients with rheumatoid arthritis.
  Medscape News UK, April 07, 2025
• Secukinumab May Protect Against Bone Erosion in PsA Secukinumab treatment reduces bone erosion volume and enhances partial healing of erosions in patients with psoriatic arthritis, according to results from a randomized controlled trial.
  Medscape Medical News, April 04, 2025
• Safety of Combo Therapy for IMIDs Requires Caution ‘I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.
  Medscape Medical News, April 01, 2025
• Should You Interrupt Arthritis DMARDs During an Infection? By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s working,’ said Jack Cush, MD.
  Medscape Medical News, April 01, 2025
• Safety of Systemic Psoriasis Rxs Studied in Older Adults The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising concerns about the risks for step therapy protocols that may delay access to these options.
  Medscape Medical News, March 31, 2025
• HZ Risk With Psoriasis Biologics, Traditional Rxs Compared In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with psoriasis.
  Medscape Medical News, March 28, 2025
• Remote Monitoring in Rheumatology: What’s Holding It Back? Varied approaches to remote patient monitoring are in development to close care gaps between patients and rheumatologists, but their use in clinical practice has a long way to go, experts said.
  Medscape Medical News, March 27, 2025
• AAD 2025 IL-23 Inhibitors Tested for Expanded Role in Psoriasis In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.
  Medscape Medical News, March 20, 2025
• Axial Involvement in PsA: What Are the Risk Factors? Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and HLA-B27 positivity associated with an increased risk for axial PsA.
  Medscape News UK, March 17, 2025
• Deucravacitinib Meets Endpoints in Phase 3 PsA Trial Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life than placebo, according to findings from a phase 3 trial.
  Medscape Medical News, March 12, 2025
• MetS and Radiographic Damage in PsA: Is There a Link? Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related radiographic damage to the axial or peripheral joints, new study reveals.
  Medscape Medical News, March 11, 2025
• Teva Pharma and Alvotech Launch Biosimilar to J&J's Stelara in US Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a...
  Reuters Health Information, February 21, 2025
• Rethinking Fibromyalgia: Nociplastic Pain’s Big Impact Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively recently recognized third category of pain.
  Medscape Medical News, February 19, 2025
• Cancer Immunotherapy May Raise Rheumatoid Arthritis Risk Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an observational study found.
  Medscape Medical News, February 14, 2025
• Joint Location Influences Response to TNF Inhibitor in PsA The resolution of joint swelling with TNF inhibitors in psoriatic arthritis varied by joint location, with higher resolution rates in the shoulder and elbow and lower rates in the wrist and knee.
  Medscape News UK, February 10, 2025
• Psoriasis Tied to Higher Cardiovascular Risk in Delivery Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular complication risks in this group of patients.
  Medscape Medical News, January 30, 2025
• Patient-Clinician Views Diverge in Psoriatic Arthritis Care A recent study on psoriatic arthritis care revealed that patients and clinicians agree on key aspects of disease management but also highlighted distinct perceptions between the two groups.
  Medscape Medical News, January 22, 2025
• New Ideas on PsA Pathogenesis May Drive New Treatments Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may become altered, leading to a worsening of symptoms.
  Medscape Medical News, January 07, 2025
• Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have cardiovascular and thrombotic risk profiles comparable with those of TNF inhibitors.
  Medscape Medical News, January 07, 2025
• Combined Psoriasis/PsA Clinics: Potential and Pitfalls Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for dermatology and rheumatology patients.
  Medscape Medical News, January 02, 2025